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propose an approach to cardiac surgery patient referral
which is based on their understanding of ethical obligation:
Risk-adjusted cardiac surgery mortality rate data for indi-
vidual cardiac surgeons are currently available for 25% of the
U.S. population . . . surveys of cardiologists and analysis of
market share data indicate this information is not being
used to refer to cardiac surgeons with the lowest mortality
rates. . . . Because the welfare of a patient will be maximally
promoted by referring that patient to the best available
surgeon, cardiologists have a responsibility to refer their
patients to the surgeon with the best risk-adjusted out-
comes. . . . The only way for cardiologists to fulfill this
ethical obligation when referring patients to cardiac sur-
geons is to refer patients to those available surgeons who
have the best outcomes . . .
Brown et al. (1) assert an ethical responsibility for
cardiologists to refer patients to the surgeon(s) with the
lowest risk-adjusted mortality rate. With an ethicist and
philosopher lending gravitas, this essay has far-reaching
implications. Practical considerations notwithstanding,
their thesis will have visceral appeal to many stakeholders.
How could one possibly argue with the notion that cardi-
ologists should refer their patients to the “best” available
surgeon with the “lowest mortality rates”?
We are strong supporters of healthcare transparency and
accountability, and we have implemented several public
reporting initiatives. We also believe in the value of more
objective, evidence-based approaches to shared decision
making and informed consent (2,3). However, we have both
ethical and methodological concerns with the current pro-
posal of Brown et al. (1). It presupposes an extremely
restrictive view of what it means to be the “best,” it makes
paternalistic judgments about what should be most important
to patients, and its expectations regarding the capabilities of
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cerns in reverse order, starting with what one can reasonably
expect from statistical profiling.
Provider Profiling: Real or Random Differences
Brown et al. (1) define “best” surgeon solely on the basis of
having the lowest risk-adjusted mortality rate. The appeal-
ing simplicity of this algorithm quickly evaporates the more
closely that we examine it. For example, what exactly do the
authors mean when they say the “lowest risk-adjusted
mortality rate”?
Medical research is conducted largely on the basis of the
principles of inferential statistics. Whether analyzing the
results of 2 treatment strategies in a clinical trial or com-
paring performance among providers, the available data are
typically limited to a sample from a larger potential universe
of observations. The statistician’s objective is to detect the
signal within the noise. Frequentist tests of statistical
significance (p values and confidence intervals), Bayesian
probabilities (with credible intervals), and graphical ap-
proaches such as funnel plots have all been used to address
this fundamental question. So we return to our original
question: What do Brown et al. (1) mean by “lowest
risk-adjusted mortality rate” or “best risk-adjusted out-
comes”? We assume that they are not suggesting a simple
ranking of surgeons by point estimates of mortality, because
absolute differences in mortality are often not statistically
significant. If they are making their recommendation on the
basis of current report cards, then they are most likely
referring to low-mortality outliers. These providers have
results that are statistically significantly different from the
average of other providers, and they are very unlikely to have
occurred by chance.
Classification of providers as high- or low-mortality outliers
is inherently complex, and numerous methodological limita-
tions must be considered when using such results for profil-
ing, public reporting, or informed consent (4). For the
purposes of this commentary, we accept that risk adjustment
using audited clinical data is reasonably effective in account-
ing for the increased risk faced by providers who care for the
most severely ill patients. However, there are other equally
challenging problems common to all coronary artery bypass
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Autonomy, Beneficence, Justice, and the Limits of Provider Profiling June 19/26, 2012:2383–6graft (CABG) profiling initiatives. First, the event rate
(risk-adjusted mortality rate) is low, typically 1% to 3%,
yielding relatively few events on which to base statistical
inferences. Second, overall sample sizes for an individual
surgeon are small if a homogeneous target population
(isolated CABG) is chosen, appropriately excluding com-
bined procedures (e.g., CABG plus valve replacement) that
are associated with a higher risk of mortality. To mitigate
small sample size, many states aggregate multiple years of
data, although the number of resulting cases may still be
100 for many surgeons. Other states use statistical esti-
mators that “shrink” the results of low-volume surgeons
toward the overall mean, thereby obtaining more precise
estimates of their true underlying rates (5–7). The Society of
Thoracic Surgeons prefers to profile at the program rather
than the individual surgeon level. This largely solves sample
size issues, brings substantial peer pressure to bear on
underperforming members of a group, and may reduce the
potential for risk aversion. It also is more consistent with the
team approach that currently characterizes most complex
medical care.
Given these practical and statistical constraints, it is not
surprising that cardiac surgeon report cards often show wide
and overlapping 95% confidence intervals, most of which
intersect with unity and are therefore not classified as
outlying. Using hierarchical statistical models to account for
small sample sizes and clustered observations, there have
been no statistical outliers among approximately 60 Massa-
chusetts cardiac surgeons in recent years (5). With a completely
ifferent statistical approach, the 2008 to 2009 results for
ennsylvania CABG procedures identified only 3 of approxi-
ately 180 cardiac surgeons (1.7%) whose risk-adjusted mor-
ality rates were statistically better than expected (8).
To further complicate matters, even confirmed status as a
ow-mortality outlier for 1 reporting period does not provide
ssurance that a surgeon is the “best.” If a particular surgeon
ere truly the best, one would expect consistency in their
uperior performance rating over time. In reality, examina-
ion of sequential state report cards often reveals that the
owest mortality rate, outlying surgeons change over succes-
ive reporting periods. Consequently, if using lowest mor-
ality rate as the sole criterion for cardiac surgeon referral,
election determined on the basis of the most recently
ublished results (which may be 6 months to several years
ld) does not guarantee that current performance is also
uperior.
The ultimate lowest mortality rate is 0%, but even this
onfers no certainty of future performance. Brown et al. (1)
ssert that it is “extremely unlikely” that referral to a surgeon
ith the lowest historical mortality rates could result in a
orse clinical outcome. In fact, dozens of surgeons in the
006 to 2008 New York cardiac surgery report cards are
eported as having a 0% risk-adjusted mortality rate at a
articular hospital (9), but many are determined on the basis
f very low volumes and have wide 95% confidence inter-
als. Aside from the futility of comparing results on the basis of such a small number of cases, regression to the mean
uggests that surgeons with a 0% mortality rate on the basis
f historical small samples could just as likely have average
r worse than average results a year later, as illustrated by the
tudy of Dimick and Welch (10).
It is important to recognize that even statistically signif-
cant differences among provider results may not have
ractical significance. Although not usually the case with
hysician profiling, it is theoretically possible for almost any
mall absolute difference to be statistically significant if the
ample size is sufficiently large, but such differences may be
rrelevant compared with other considerations.
Finally, virtually all report cards use indirect standardiza-
ion to compute expected mortality rates, and this approach
mposes constraints on their interpretation. The resulting
isk-standardized mortality rates assess the performance of
urgeons for the cases they actually treated. Some surgeons
ay perform very well given their particular patient cohort,
ut this does not guarantee a similar level of performance if
he same surgeons were confronted with a different (e.g.,
ore complex) mix of patients (11).
eneficence
he preceding discussion outlines the statistical problems of
lassifying a provider as having the “lowest mortality rate.”
or the sake of argument, assume for the moment that this
etermination can be made with acceptable accuracy. Given
hat assumption, would it then be reasonable to equate
lowest mortality rate” with “best”?
Beneficence is one of the most important obligations of
hysicians to their patients, a foundational principle of
edical ethics since the time of Hippocrates (12). Physi-
ians have a responsibility to promote the welfare of their
atients, by both doing good and actively avoiding potential
arm. On the basis of this principle, it would seem that
eferral only to the “best surgeon” would be perfectly
onsistent with this ethical goal. But is beneficence the only
thical principle to be considered?
utonomy
he goal of beneficence often runs afoul of another equally
mportant ethical principle—patient autonomy—and bal-
ncing the two is among the most contentious issues in
edical ethics (12). Who should ultimately define what is in
he best interest of patients? Before the current era of
atient centeredness, promoted by the Institute of Medicine
s 1 of 6 key aims to improve health care, the physician was
ypically assumed to have the answer to this question.
xhibiting various degrees of paternalism, physicians either
resumed that their actions were promoting the perceived
oals of their patients or, in extreme cases, simply substi-
uted their own values and judgments, believing them to
etter accomplish what the patient should want.
So how do the potentially conflicting ethical principles ofeneficence and autonomy play out in the referral scheme of
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June 19/26, 2012:2383–6 Autonomy, Beneficence, Justice, and the Limits of Provider ProfilingBrown et al. (1)? On the one hand, it seems completely
reasonable to presume that short-term (in-hospital or 30
days) survival is the most important criterion for patients in
selecting a provider. But is that necessarily the case? In
selecting caregivers for their own families, most physicians
we know would not feel compelled to only use a specialist
with the lowest reported mortality rate, because they recog-
nize there are many facets to being an outstanding physi-
cian. If published mortality rates are not the only criterion
that physicians would use to select a provider for their own
care, perhaps it is not so unreasonable to ask why this should
be any different for their patients.
Consider some real-life scenarios. For example, what if
the surgeon with the lowest risk-adjusted mortality rate used
operative techniques that resulted in substantially increased
incidence of nonfatal but debilitating complications such as
sternal infection or stroke? What if the surgeon with the
“best” 30-day CABG mortality rates had inferior long-term
outcomes because they infrequently used internal mammary
artery grafts or inconsistently prescribed important medica-
tions for secondary prevention (e.g., aspirin, statin drugs)?
What if this “best” surgeon was arrogant, aloof, and never
available to answer questions? What if the “best” surgeon
did not follow-up with patients and their referring doctors
after discharge to coordinate long-term care? What if the
“best” surgeon were located hundreds of miles across the
state? Any of these considerations might lead even a
sophisticated patient to rationally choose a physician other
than the one with the “lowest mortality rate.” Patients do, in
fact, often choose on the basis of reasoning that physicians
may find illogical and frustrating, but which is still their
right. For example, Finlayson and colleagues (13) found that
patients would often risk 3 to 4 times greater mortality for
pancreatic surgery rather than have to travel to a distant
regional referral center.
A patient’s choice of a physician may involve many
considerations, not just short-term survival but also compli-
cation rates, patient-reported outcomes, convenience, famil-
iarity, and interpersonal skills. As noted by Professor Judith
Hibbard (14), “consumers’ conceptualization of quality of
care differs from the way in which it is measured and
reported publicly.” Interestingly, the current proposal by
Brown et al. (1) differs dramatically from the more inclusive,
patient-centered approach taken by the lead author in
another recent publication (15), which we find much more
persuasive:
Historically, end points studied in retrospective analyses of
CABG outcomes are those that can be relatively easily
measured such as in-hospital or 30-day mortality. However,
in my experience, patients (and their families) are equally
concerned about different outcomes that are not so easily captured
and analyzed but are certainly related to quality—at least from
the patient’s perspective. That is, they want to know the
chances that they are going to survive the operation without
major complications such as stroke, cognitive dysfunction,
kidney failure, major myocardial infarction, wound infec- btion, ventilator dependence, or the need for a prolonged
recovery in a nursing home.
Although it is the only outcome that is publicly reported,
mortality is just one dimension of many relevant outcomes.
In addition, out-of-hospital outcomes beyond 30 days,
which are rarely studied, are also important from the patient
perspective. These include survival, return to normal or
improved function, relief of symptoms, and avoidance of
hospital readmission and additional procedures . . . . it is
possible that patients fear a stroke more than they fear
death. There are no data regarding the relative value placed
on different adverse outcomes following CABG.
Ultimately, the tension between beneficence and autonomy
is best resolved through the process of shared decision making
(2). This optimally includes all relevant information that would
ssist patients in making their decision, presented clearly and
mpartially by the physician in such a way that their own biases
nd preferences do not dominate the process.
ustice and Risk Aversion
n addition to beneficence and patient autonomy, the
roposal of Brown et al. (1) also affects a third ethical
bligation of physicians—justice. If mortality becomes the
ole criterion on which to base cardiac surgery referrals, then
urgeons may become even more risk averse than has already
een observed in some public reporting states (16). This
nintended negative consequence may limit access to sur-
ery for 2 classes of patients: those with a high calculated
isk of postoperative mortality (e.g., using The Society of
horacic Surgeons risk model), and those patients belong-
ng to racial or ethnic minorities who may be subjectively
egarded by surgeons as being high risk (4,17).
ecommendation
e agree with Brown et al. (1) that there is an ethical
bligation to assess and publish provider performance re-
ults, although there remains legitimate controversy about
hether this should be at the hospital or individual physi-
ian level (or both). Such reports must be made more
nderstandable and accessible to consumers (18). Patient-
pecific risk estimates and provider performance results
hould be included in the portfolio of relevant information
onveyed to patients during the process of shared decision
aking. Although not emphasized by Brown and colleagues
1), we also believe that ethical conduct by cardiologists always
equires full and unbiased discussion of alternative treat-
ent strategies (e.g., percutaneous coronary intervention,
ABG), not just the choice of an interventionalist or
urgeon once that decision is made.
We do not accept that it is scientifically reasonable, ethically
ustified, or realistic to require that cardiologists must refer only
o the “best” cardiac surgeon as defined by having the lowest
isk-adjusted mortality rate. From a statistical perspective, it is
ifficult to identify significantly high-performing outliers on the
asis of relatively small sample sizes and low event rates, and
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continues to play a major role even with sophisticated profiling
techniques. Consistent low-mortality outlier status over successive
reporting periods suggests that the high performance is systematic
rather than random, but this is uncommonly observed. Con-
versely, patients should be wary of surgeons or hospitals with
consistently low performance (e.g., high mortality).
Methodological issues notwithstanding, it is unreasonable to
define “best” surgeon on the basis of only one outcome, risk-
adjusted mortality rate, as important as that may be. Patient
autonomy must always take precedence, and patients appro-
priately consider many different priorities—operative survival,
avoidance of serious complications, a compassionate and caring
provider, the likelihood of early and sustained return of
function, long-term survival, freedom from recurrent symp-
toms, and convenience. Composite measures of performance
that encompass multiple domains of quality must be devel-
oped. Not only do they promote the Institute of Medicine goal
of multidimensional quality measurement (19), but they also
provide additional endpoints and thus facilitate statistical
discrimination among providers.
Ideally, any decision regarding referrals must thoughtfully
attempt to match the history, clinical presentation, intended
procedure, goals, and personality of a specific patient with
the experience, capabilities, performance, and demeanor of
available surgeons. This approach is most likely to yield the
“best” outcome from all relevant perspectives.
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